21 May 2009
Analysis of risk factors of postoperative haemodialysis treatment in kidney transplant recipients
M Zukowski, R Bohatyrewic, J Biernawska, K Katarzyna, M Zegan, M Ostrowski, I Sulikowski, K KedzierskaAnn Transplant 2009; 14(1): 48-48 :: ID: 880374
Abstract
Background: The quality of the transplanted kidney depends on many factors
that may debilitate its function, what can result in the necessity of haemodialysis treatment in the post operative period. Aims: Determining the influence of selected risk factors on the duration and number of haemodialysis post transplantation.
Material/Methods: Hemodynamic data was obtained from a group of 146
multi-organ donors. Group of 232 kidney transplant recipients was included in this study. Influence of the following factors on the duration and number of haemodialysis sessions in the postoperative period was analyzed: PRA value, HLA matching, length of haemodialysis prior to transplantation, donor's age and risk factors: MAP, CVP, PCWP, SVRI, dopamine infusion and CIT. Shapiro-Wilk, Kruskal-Wallis, Chi2 with the Yates correction and Fisher tests and analysis of correlation and regression were used, p=0.05.
Results: Decreased duration and fewer dialysis sessions were observed in the recipients, who had their kidney transplanted from the donors with MAP >70 mmHg, PCWP >12 mmHg and dopamine infusion <10 μg/kg/min. Positive correlation was observed between BSA, dopamine dose infusion, recipient's
age, length of haemodialysis prior to transplantation and the duration of the haemodialysis required post transplant.
Conclusions: 1) Increased MAP and PCWP in the donor both have a major influence on decreasing the duration of haemodialysis of kidney recipient post transplantation; 2) Increased BSA, dopamine dose infusion requirements in the donor, age and duration of haemodialysis before transplantation substantially prolong the duration of haemodialysis post transplantation.
Keywords: Kidney Transplantation, Organ Procurement
In Press
Case report
Tongue Carcinoma in Immunosuppressed Patients After Liver and Kidney Transplantation: A Case SeriesAnn Transplant In Press; DOI: 10.12659/AOT.951715
Original article
Prevalence and Risk Factors of Hepatic Steatosis in Kidney Transplant RecipientsAnn Transplant In Press; DOI: 10.12659/AOT.952251
Original article
The Anatomical Landscape of Living Donor Livers: A 101-Case Retrospective Single-Center Study in Indonesia ...Ann Transplant In Press; DOI: 10.12659/AOT.952031
Original article
Decreased Ventilation Duration and ICU Stay Associated With Early Percutaneous Dilatational Tracheostomy Af...Ann Transplant In Press; DOI: 10.12659/AOT.953143
Most Viewed Current Articles
24 Aug 2021 : Review article 20,545
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
29 Dec 2021 : Original article 16,641
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588
05 Apr 2022 : Original article 15,898
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 15,796
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988






